HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qianying Liu Selected Research

ErbB Receptors (EGF Receptor)

1/2023AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
1/2022AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2- advanced breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qianying Liu Research Topics

Disease

7Neoplasms (Cancer)
02/2024 - 07/2017
4Infections
12/2023 - 01/2017
4Pain (Aches)
01/2019 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2023 - 12/2017
3Multiple Myeloma
01/2020 - 01/2019
3Hyperalgesia
01/2019 - 01/2018
3Body Weight (Weight, Body)
01/2018 - 01/2017
2Carcinogenesis
02/2024 - 05/2019
2Bacterial Infections (Bacterial Infection)
12/2023 - 09/2019
2Inflammation (Inflammations)
12/2023 - 01/2018
2Bone Neoplasms (Bone Cancer)
01/2019 - 01/2018
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2018 - 01/2017
2Chronic Obstructive Pulmonary Disease (COPD)
01/2018 - 01/2018
1Non-alcoholic Fatty Liver Disease
02/2024
1Type 2 Diabetes Mellitus (MODY)
12/2023
1Genetic Predisposition to Disease (Genetic Predisposition)
12/2023
1Genetic Risk Score
12/2023
1Acute Kidney Injury (Acute Renal Failure)
12/2023
1Hypocalcemia
11/2023
1Hypokalemia
11/2023
1Anemia
11/2023
1Acidosis
11/2023
1Cardiac Arrhythmias (Arrythmia)
11/2023
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Heart Failure
11/2023
1Kidney Diseases (Kidney Disease)
11/2023
1Neoplasm Metastasis (Metastasis)
01/2023
1Pulmonary Tuberculosis
01/2023
1Tuberculosis (Tuberculoses)
01/2023
1COVID-19
01/2022
1Dementia (Dementias)
01/2021
1Hypotension (Low Blood Pressure)
03/2020
1Lymphoma (Lymphomas)
01/2020
1Mastitis
10/2019
1Hypersensitivity (Allergy)
01/2019
1Chronic Pain
01/2019
1Stroke (Strokes)
01/2019
1Neuralgia (Stump Neuralgia)
01/2019

Drug/Important Bio-Agent (IBA)

4plerixaforFDA Link
01/2020 - 01/2019
3ArsenicIBA
02/2024 - 11/2023
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 01/2019
2Cyclin-Dependent Kinase 4IBA
01/2023 - 01/2022
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2022
2Estrogen ReceptorsIBA
01/2023 - 01/2022
2Neutralizing AntibodiesIBA
01/2022 - 01/2019
2marbofloxacinIBA
01/2017 - 01/2017
1ORALIT (ORS)IBA
02/2024
1Insulin (Novolin)FDA Link
02/2024
1Insulin-Like PeptidesIBA
02/2024
1Glucose (Dextrose)FDA LinkGeneric
02/2024
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2024
1Peptides (Polypeptides)IBA
12/2023
1EnzymesIBA
12/2023
1Cisplatin (Platino)FDA LinkGeneric
12/2023
17-hydroxycoumarin (umbelliferone)IBA
12/2023
1Parathyroid Hormone (Parathormone)IBA
11/2023
1NitrogenIBA
11/2023
1CreatinineIBA
11/2023
1Urea (Carbamide)FDA LinkGeneric
11/2023
1MicroRNAs (MicroRNA)IBA
11/2023
1CarcinogensIBA
11/2023
1Bispecific AntibodiesIBA
10/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
10/2022
1EpitopesIBA
01/2022
1Letrozole (Femara)FDA LinkGeneric
01/2022
1AntibodiesIBA
01/2022
1palbociclibIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Aromatase InhibitorsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2020
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2020
1pomalidomideIBA
11/2019
1isatuximabIBA
11/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2019
1Lipid NanoparticlesIBA
10/2019
1HydrogelsIBA
10/2019
1tilmicosinIBA
10/2019
1AlginatesIBA
10/2019
1ChitosanIBA
10/2019
1polyethylene glycol polyethyleneimine nanogelIBA
10/2019
1Anti-Infective Agents (Microbicides)IBA
09/2019
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
05/2019
1SB 225002IBA
01/2019
1ChemokinesIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1AcidsIBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2019
1CaspasesIBA
01/2019
1Glial Fibrillary Acidic ProteinIBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019

Therapy/Procedure

2Therapeutics
01/2023 - 12/2017
2Hematopoietic Stem Cell Mobilization
01/2020 - 01/2020
2Transplantation
01/2020 - 01/2019
1Retreatment
01/2023
1Spinal Anesthesia
03/2020
1Hematopoietic Stem Cell Transplantation
01/2020
1Blood Component Removal (Apheresis)
01/2019
1Radiofrequency Ablation
01/2019